about
Vitamin C and superoxide dismutase (SOD) for diabetic retinopathyAssessment of retinal and choroidal blood flow changes using laser Doppler flowmetry in rats.Effect of intravitreal injection of ranibizumab on retinal ganglion cells and microvessels in the early stage of diabetic retinopathy in rats with streptozotocin-induced diabetesInhibition of reactive oxygen species by Lovastatin downregulates vascular endothelial growth factor expression and ameliorates blood-retinal barrier breakdown in db/db mice: role of NADPH oxidase 4.Preconditioning with endoplasmic reticulum stress mitigates retinal endothelial inflammation via activation of X-box binding protein 1.Automated detection of proliferative retinopathy in clinical practiceIcariin ameliorates streptozotocin-induced diabetic retinopathy in vitro and in vivo.Endoplasmic reticulum stress and inflammation: mechanisms and implications in diabetic retinopathy.Losartan and ozagrel reverse retinal arteriolar constriction in non-obese diabetic miceBrazilian Green Propolis Improves Antioxidant Function in Patients with Type 2 Diabetes Mellitus.Advanced glycation end products and diabetic retinopathy.Role of β3-adrenoceptors in regulation of retinal vascular tone in rats.Sustained moderate visual loss as a predictive end point for visual loss in non-proliferative diabetic retinopathy.Stimulation of β1- and β2-adrenoceptors dilates retinal blood vessels in rats.Extract of Litsea japonica ameliorates blood-retinal barrier breakdown in db/db mice.Metabolomics study of diabetic retinopathy using gas chromatography-mass spectrometry: a comparison of stages and subtypes diagnosed by Western and Chinese medicine.Probucol prevents the attenuation of β2-adrenoceptor-mediated vasodilation of retinal arterioles in diabetic rats.
P2860
Q24242326-7780C3BC-1CC4-4BE0-B8A1-FA4AE153B71BQ31094001-D6EA0FC1-6288-4821-89B6-478476F00885Q33744652-C26E248B-7A97-4FF8-94DF-271F4BD91846Q33869840-246881E4-CBE9-499D-B2D5-07B71138B185Q34575640-38A779DD-24E0-4096-B182-ED142034086FQ34996605-46853908-51E7-4F63-8DAE-F5AFE12EA87BQ35719498-AE354DA4-8D07-48A2-B535-49BEF6FAEB25Q35928460-8A2A76FE-8FDD-4FDD-BCF0-A53682B63A71Q36857431-7B5935C3-C1B5-4569-9C26-8F979BDD3E7FQ36937992-CB639278-36C5-4FFD-BF35-A7C00A9B89FFQ37930514-A6100E4B-F7F8-40F5-844A-119A7C602CDFQ39997948-4144884E-A5DE-42B1-ABEE-4EBDE058E06BQ40029578-69583F45-D5E8-4AF4-BAAA-8F70DA48EDE0Q40441138-DAF3EC10-BD01-4508-B55D-3E2194E43C30Q44418091-1C7DD8EF-B604-415D-945F-5F951F177707Q47299139-A5A9EF80-5DA4-42F1-ADE2-9B098CFD01FEQ50076040-DB71AD6B-43F6-411F-85B1-2E926E88F5BC
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Pharmacological approach to diabetic retinopathy.
@ast
Pharmacological approach to diabetic retinopathy.
@en
type
label
Pharmacological approach to diabetic retinopathy.
@ast
Pharmacological approach to diabetic retinopathy.
@en
prefLabel
Pharmacological approach to diabetic retinopathy.
@ast
Pharmacological approach to diabetic retinopathy.
@en
P50
P356
P1476
Pharmacological approach to diabetic retinopathy
@en
P2093
Felipe Sánchez de la Cuesta
P304
P356
10.1002/DMRR.432
P577
2004-03-01T00:00:00Z